Results 91 to 100 of about 17,715 (228)
JHLT OpenPurpose: Understanding LVAD self-care needs is important for candidacy decisions and care planning. This study investigated the association between pre-operative occupational therapy (OT) evaluations and post-operative LVAD self-care, length of stay (LoS)
Jessica D. Asiello, OT, OTD, OTR +7 more
doaj +1 more source
Biomedical Papers, 2016 Aims: One of the proposed limitations of left ventricular assist device (LVAD) therapy is high degree of sensitization. Apart from human leukocyte antigen (HLA), antibodies against Angiotensin II Type 1 Receptor (AT1R) have been associated with adverse ...
Marian Urban +4 more
doaj +1 more source
Circulation Research, 2017 Left ventricular assist devices (LVADs) are efficient pumps that assist the circulation. They are rapidly evolving and being inserted into an increasing number of patients with advanced heart failure either as a bridge to transplantation or increasingly as destination therapy.
openaire +2 more sources
Artificial Organs, Volume 50, Issue 9, Page 1295-1304, September 2026.Shear‐induced blood damage—including hemolysis, platelet and neutrophil injury, and von Willebrand factor (vWF) degradation—was evaluated for the BrioVAD and HM3 using an in vitro circulatory loop under clinically relevant conditions. Across 15 biomarkers (n > 6 per group), no significant differences were observed between the two devices.
Wenji Sun +9 more
wiley +1 more source
Apixaban in bridge to transplant and destination LVAD - rationale and study design: the ApixiVAD trial. [PDF]
AIMS Use of novel anticoagulation in mechanical circulatory support is controversial. We report the rationale and design of the ApixiVad pilot trial, a pilot study testing the safety of apixaban as an anticoagulant in patients bridged to transplant ...
Ricardo Deveza +5 more
core +2 more sources
Long-term left ventricular assist device support reinforces detrimental immunological effects
Frontiers in ImmunologyIntroductionInfection is a common complication following left ventricular assist device (LVAD) implantation that increases the mortality in the post-implantation period. Immunological changes affecting dendritic cells (DCs), natural killer (NK) cells and
Maja-Theresa Dieterlen +8 more
doaj +1 more source
Artificial Organs, Volume 50, Issue 9, Page 1305-1314, September 2026.This mixed methods study aimed to: (i) identify treatment expectations held by individuals with a ventricular assist device (VAD), (ii) assess the extent to which these expectations have been met, and (iii) examine how treatment expectations relate to VAD‐specific health‐related quality of life (HRQoL) ABSTRACT Objectives Treatment expectations ...
Simon Felix Zerth +10 more
wiley +1 more source
LVAD Driveline Infection Readmission: Prevention by Standardization
, 2018 Recurrent driveline infection is the most common readmission diagnosis for patients after being implanted with an LVAD. The literature shows that readmission on post LVAD implantation on average costs $35,000.
Goodwin, Casey +2 more
core +1 more source
Implantable devices: a bridge to heart transplantation
Вестник трансплантологии и искусственных органов, 2019 Terminal stage heart failure represents a substantial worldwide problem for the healthcare system. Despite significant improvements (medical heart failure treatment, implantable cardioverters, cardiac resynchronization devices), long-term survival and ...
D. Zimpfer, D. Wiedemann, A. Neissner
doaj +1 more source
Clinical Transplantation, Volume 40, Issue 9, September 2026.ABSTRACT Background Predicted heart mass (PHM) is widely used for donor–recipient size matching in heart transplantation, yet its relevance to early graft performance in the modern allocation era remains uncertain. Emerging data suggest that left and right ventricular mismatch may exert distinct physiologic effects that are obscured by total PHM ...
Awab Ahmad +24 more
wiley +1 more source